Medite Cancer Diagnostics, Inc. (CYOE) financial statements (2020 and earlier)

Company profile

Business Address 414 NORTH ORLEANS STREET
CHICAGO, IL 60610
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments001000
Cash and cash equivalents001000
Receivables012200
Inventory, net of allowances, customer advances and progress billings2433
Inventory2433  
Prepaid expense and other current assets0
Other undisclosed current assets10000 
Total current assets:356600
Noncurrent Assets
Property, plant and equipment222200
Intangible assets, net (including goodwill)5552
Goodwill5552  
Other noncurrent assets0000 
Other undisclosed noncurrent assets6666  
Total noncurrent assets:1212131100
TOTAL ASSETS:1618181600
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:333455
Accounts payable11  01
Accrued liabilities333311
Employee-related liabilities11 233
Taxes payable    00
Interest and dividends payable   0  
Other undisclosed accounts payable and accrued liabilities(2)(2) (2)  
Debt(0)(3)(3)300
Due to related parties000003
Other undisclosed current liabilities076 (0)(0)
Total current liabilities:476748
Noncurrent Liabilities
Long-term debt and lease obligation5001  
Long-term debt, excluding current maturities5001  
Liabilities, other than long-term debt223   
Deferred tax liabilities, net122   
Due to related parties001   
Total noncurrent liabilities:6231  
Total liabilities:10109848
Stockholders' equity
Stockholders' equity attributable to parent6898(4)(7)
Preferred stock111111
Common stock000000
Treasury stock, value(0)(0)(0)(0)(0)(0)
Common stock, value, subscriptions 0  
Additional paid in capital149869793
Accumulated other comprehensive loss(0)(1)(1)(0)  
Retained earnings (accumulated deficit)(8)(1)12(103)(102)
Total stockholders' equity:6898(4)(7)
TOTAL LIABILITIES AND EQUITY:1618181600

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
79101100
Cost of revenue(7)(6)(6)(7)(0)(0)
Gross profit:044400
Operating expenses(1)(2)(1)(2)(1)(2)
Other undisclosed operating income (loss)(5)(4)(3)(3)00
Operating loss:(6)(2)(1)(0)(1)(1)
Nonoperating expense(1)(1)(0)(0)(0)(0)
Other nonoperating income0000  
Interest and debt expense(0)(0)(0) 00
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes000 (0)(0)
Loss from continuing operations before income taxes:(7)(2)(1)(1)(1)(2)
Income tax expense (benefit)00(0)(0)  
Net loss attributable to parent:(7)(2)(1)(1)(1)(2)
Preferred stock dividends and other adjustments(0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(7)(2)(1)(1)(1)(2)

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(7)(2)(1)(1)(1)(2)
Other comprehensive income (loss)0(0)(0)   
Comprehensive loss:(7)(2)(1)(1)(1)(2)
Other undisclosed comprehensive loss, net of tax, attributable to parent   (0)  
Comprehensive loss, net of tax, attributable to parent:(7)(2)(1)(1)(1)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: